$AADX

Applied Aerospace & Defense raises $650M in an IPO the market wanted ten times over

Applied Aerospace & Defense priced its NYSE IPO at $20/share, raising $650M, after the book was reportedly about 10x oversubscribed. The Huntsville, Alabama firm sold 32.5M shares (below its $18–$21 range). It begins trading Wednesday under ticker AADX; the offering valued it at about $3.4B. Morgan Stanley and Jefferies led, with other joint bookrunners listed in filings.

Original reporting
Published Jun 3, 2026, 9:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 9:58 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Applied Aerospace & Defense raises $650M in an IPO the market wanted ten times over — source image
Decision brief

The 30-second read

$AADXBullishMed
01

Why it matters

The immediate tradable event is the IPO pricing and the start of NYSE trading, with demand signals (~10x oversubscribed) that often translate into opening volatility and momentum flows.

02

Market read

A defense-hardware supply-chain IPO with strong demand signals is set to trade on the NYSE, making opening liquidity and momentum the near-term focus.

03

What to watch

Customer concentration and order-book durability (including whether Anduril’s demand compounds) are the key risk to valuation beyond the IPO day narrative.

Relevance 9/10Novelty 8/10Timing: Begins trading on the NYSE on Wednesday (next session after pricing).

Background

Applied Aerospace & Defense (fuselage sections, solid rocket motor cases, flight-control/structural components) is a legacy supplier founded in 1954, not a pre-revenue defense startup.

Company-level read

Ticker impact

$AADXBullishMedium confidence
Context

Applied Aerospace & Defense priced its IPO at $20, raised $650M, and begins NYSE trading Wednesday under AADX.

Expected impact

Likely first-day pop/volatility given ~10x oversubscription and IPO pricing near the top of range.

Evidence & confidence

The article provides concrete IPO terms (price, shares, raise size), oversubscription level, and the imminent start of trading—key inputs for opening-range positioning.

Market effects

Reinforces investor re-rating of defense hardware supply-chain names, potentially improving sentiment for other defense-adjacent IPOs/secondaries.

Highlights US defense manufacturing demand (Huntsville, Alabama) as a beneficiary of sustained US spending.

Supports the broader global defense-budget upcycle narrative, though the direct catalyst is company-specific IPO demand.

Counterpoint

Oversubscription can fade quickly if post-IPO trading implies the market is overpaying for budget growth that politics may not sustain.

Key entities

  • Applied Aerospace & Defense

    IPO priced at $20/share; raised $650M; starts trading Wednesday on NYSE as AADX.

  • Anduril

    Named as a buyer, used to support investor demand for the supplier’s order book.

  • Boeing

    Listed among customers, supporting the legacy-prime supply-chain thesis.

  • GE Aerospace

    Listed among customers, reinforcing established certification/history demand.

Related articles

$AADXMedAI 9/10

Applied Aerospace & Defense Prices IPO At $20/Shr

Applied Aerospace & Defense (AADX) priced its IPO at $20 per share for 32.5 million shares, with expected gross proceeds of about $650 million, before underwriting discounts and expenses, according to the company. The offering is set to close Thursday. Underwriters have a 30-day option to buy up to 4.875 million more shares. Shares are expected to start trading on the NYSE Wednesday under ticker AADX.

$AADXMedAI 9/10

Applied Aerospace & Defense, Inc. Prices Initial Public Offering

Applied Aerospace & Defense, Inc. priced its IPO of 32.5 million shares at $20.00 per share, with a 30-day underwriters’ option to buy up to 4.875 million additional shares at the same price (per the company). Shares are expected to start trading on the NYSE on June 3, 2026 under ticker “AADX,” with closing expected June 4.

$HOODMed

Robinhood’s new venture fund comes with a bold risk label

Robinhood is launching Robinhood Ventures Fund II (ticker RVII), a business development company offering 8 million shares at $25 each starting Aug. 13. The fund plans to raise $200 million, led by Goldman Sachs. It invests in Y Combinator-linked seed startups and charges a 2% management fee plus a 20% incentive fee, with estimated annual expenses of 4.18%. The prospectus labels the offering speculative and warns of potential discounts to net asset value.